Ganub, Freyll Shad .

HRN: 21-63-21  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2023
AMPICILLIN 250MG (VIAL)
07/09/2023
07/15/2023
IVT
200mg
Q6
PCAP C
Waiting Final Action 
07/09/2023
CEFUROXIME 750MG (VIAL)
07/09/2023
07/16/2023
IV
260mg
Q8
PCAP C
Waiting Final Action 
07/12/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
07/12/2023
07/17/2023
PO
2ml
OD
PCAP-C
Waiting Final Action 
07/12/2023
CEFTRIAXONE 1G (VIAL)
07/12/2023
07/18/2023
IV
800mg
OD
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: